Forteza oral spray 0.15% bottle 30 ml

The active ingredient of the drug Forteza – benzydamine – an NSAID with analgesic and anti-exudative properties. In addition, when applied topically, benzydamine acts as a disinfectant. Its effectiveness when applied topically is due to its ability to penetrate the epithelial layer and reach effective concentrations in inflamed tissues.

When applied topically at the indicated concentration, benzydamine is absorbed by the mucous membrane, but its concentration in the blood plasma is so low that it cannot produce any pharmacological effect.

Benzydamine is excreted from the body mainly in the urine in the form of inactive metabolites or conjugation products.

Forteza, rinsing solution. Use only for rinsing the mouth. Do not exceed the recommended dose.

Adults and children over 12 years of age should rinse their mouth for 20-30 seconds using one measuring cap (15 ml) of the rinse solution. Then spit out the liquid without swallowing it. The rinse dose (15 ml) can be diluted with the same amount of water if necessary.

The procedure is repeated 2-3 times at intervals of 3-4 hours, unless the doctor has recommended a different regimen. If necessary, the number of rinses can be increased to 5.

The duration of treatment is determined by the doctor individually. It is recommended not to use the drug for more than 7 days without consulting a doctor.

Forteza, oral spray. Before use, the sprayer must be installed. When you press the pump, an aerosol is formed containing 1 dose of spray – 0.18 ml.

Dosage: Adults: 4-8 sprays 2-6 times a day. Children aged 6-12 years: 4 sprays 2-6 times a day. Children 4-6 years: 1 spray for every 4 kg of body weight, up to a maximum dose equivalent to 4 sprays 2-6 times a day.

Do not exceed recommended doses.

Hypersensitivity to any of the components of the drug.

Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness.

Adverse reactions are classified according to frequency of occurrence: very common (≥1/10); common (≥1/100 to 1/10); uncommon (≥1/1000 to 1/100); rare (≥1/10,000 to 1/1,000); very rare (<1/10,000); frequency unknown (cannot be estimated from the available data).

Gastrointestinal tract: rarely – burning sensation in the mouth, dry mouth; frequency unknown – oral hypoesthesia, nausea, vomiting, swelling and discoloration of the tongue, change in taste.

On the part of the immune system: rarely – hypersensitivity reactions; frequency unknown – anaphylactic reactions.

Respiratory, thoracic and mediastinal disorders: very rarely – laryngospasm; frequency unknown – bronchospasm.

Skin and subcutaneous tissue disorders: uncommon – photosensitivity; very rare – angioedema; frequency unknown – rash, itching, urticaria.

From the nervous system: frequency unknown – dizziness, headache.

The drug contains parahydroxybenzoates (methylparaben), which may cause delayed allergic reactions.

If the symptoms of the disease do not decrease within 3 days, the doctor determines the appropriateness of further treatment.

Some patients have experienced ulcers of the buccal and pharyngeal mucosa. If these patients do not improve, they should consult a doctor (dentist).

Benzydamine is not recommended for use in patients with hypersensitivity to salicylic acid or other nonsteroidal anti-inflammatory drugs.

The use of the drug may cause bronchospasm in patients with asthma or a history of asthma. Such patients should be warned about this.

Long-term treatment with benzydamine may lead to hypersensitivity reactions.

Forteza, an oral spray, contains parahydroxybenzoate (methylparaben), which may cause a delayed allergic reaction.

For athletes: the use of medicines containing ethyl alcohol may give a positive result in an anti-doping test (subject to restrictions set by some sports federations).

Avoid contact of the drug with the eyes.

Forteza, a solution for rinsing, is used for the oral cavity, without diluting. The solution should not be swallowed after use, but should be spit out. If the patient complains of burning or tingling, it is recommended to dilute the drug.

Use during pregnancy or breastfeeding. Pregnancy. There have been no adequate studies, so it is not recommended to use the drug in this group of patients.

Breastfeeding. Sufficient studies have not been conducted, therefore it is not recommended to use the drug during breastfeeding.

Ability to influence the reaction rate when driving vehicles or using other mechanisms. Topical application of benzydamine in recommended doses does not alter the ability to drive vehicles or operate other mechanisms.

Children. The use of the drug in solution form is not recommended in children under 12 years of age due to the possibility of swallowing it while rinsing the mouth. The drug in spray form is not recommended for children under 4 years of age.

Not reported.

There have been no reports of overdose with topical benzydamine.

However, it is known that benzydamine, when ingested in high doses (hundreds of times higher than the possible dose of this dosage form), especially in children, can cause agitation, convulsions, tremor, nausea, increased sweating, ataxia, vomiting. Such an acute overdose requires immediate gastric lavage, treatment of water and electrolyte disorders and symptomatic treatment, adequate hydration.

At a temperature not exceeding 25 °C in a place protected from light.